LACK OF PLACEBO-EFFECT ON AMBULATORY BLOOD-PRESSURE

被引:121
作者
MANCIA, G [1 ]
OMBONI, S [1 ]
PARATI, G [1 ]
RAVOGLI, A [1 ]
VILLANI, A [1 ]
ZANCHETTI, A [1 ]
机构
[1] UNIV MILAN,CATTEDRA MED INTERNA & CLIN MED,MILAN,ITALY
关键词
AMBULATORY BLOOD PRESSURE MONITORING; PLACEBO EFFECT; ANTIHYPERTENSIVE DRUG TRIALS;
D O I
10.1016/0895-7061(94)00250-F
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Several studies have reported that, at variance with clinic blood pressure, ambulatory blood pressure is not reduced by treatment with placebo. However, this evidence has usually been obtained in small groups of subjects and no data are available from a larger sample of patients. To address this issue we have analyzed data from 116 outpatients involved in placebo-controlled studies on antihypertensive treatment. The patients were studied before and at the end of a 6- to 8-week period of placebo. In all patients, blood pressure was measured by sphygmomanometry and over the 24 h by automatic ambulatory monitoring. Administration of placebo was accompanied by a significant reduction in systolic and diastolic clinic blood pressure (-5.3 +/- 1.1 and -4.4 +/- 0.6 mm Hg, respectively; P < .01), but not in 24-h, daytime and nighttime blood pressure. Hourly systolic and diastolic blood pressure profiles were virtually superimposable in the two different periods, except for the first 4 h, in which systolic blood pressure was slightly but significantly lower during than before placebo (149.5 +/- 1.2 v 146.4 +/- 1.2 mm Hg; P < .05). These results provide a large database indicating that 24-h average blood pressure is-not reduced by placebo, thus it is not necessary to include a placebo control group in antihypertensive drug studies in which ambulatory blood pressure monitoring is employed. A small placebo effect occurs, however, in the first hours of ambulatory monitoring. This may lead to a slight overestimation of the peak blood pressure effect of a drug and an underestimation of its trough-to-peak ratio if placebo correction of the data is not made or if the first part of ambulatory blood pressure monitoring is not excluded from data analysis.
引用
收藏
页码:311 / 315
页数:5
相关论文
共 9 条
[1]  
Gould, Mann, Davies, Et al., Does placebo lower blood pressure?, Lancet, 2, pp. 1377-1381, (1981)
[2]  
Dupont, van der Niepen, Six, Placebo does not lower ambulatory blood pressure, Br J Clin Pharmacol, 24, pp. 106-109, (1987)
[3]  
Mutti, Trazzi, Omboni, Et al., Effect of placebo on 24-hour non-invasive ambulatory blood pressure, J Hypertens, 9, pp. 361-364, (1991)
[4]  
Mancia, De Cesaris, Fogari, Et al., Evaluation of the antihypertensive effect of once-a-day trandolapril by 24-hour ambulatory blood pressure monitoring, The American Journal of Cardiology, 70, pp. 60D-66D, (1992)
[5]  
Mancia, 24-Hour antihypertensive effect of verapamil sustained release 240 mg versus nitrendipine and enalapril in essential hypertension, High Blood Press, 2, pp. 241-248, (1993)
[6]  
Omboni, Ravogli, Fogari, Et al., Effects of once-a-day fosinopril on 24 hour ambulatory blood pressure in mild and moderate essential hypertension, High Blood Press, 3, pp. 103-107, (1994)
[7]  
Zanchetti, Antihypertensive effects of nifedipine GITS on clinic and ambulatory blood pressures, High Blood Press, 3, pp. 45-56, (1994)
[8]  
Groppelli, Omboni, Parati, Et al., Evaluation of non-invasive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24-hour intra-arterial blood pressure, Hypertension, 20, pp. 227-232, (1992)
[9]  
Staessen, Thijs, Clement, Et al., Ambulatory pressure decreases on long-term placebo treatment in older patients with isolated systolic hypertension, J Hypertens, 12, pp. 1035-1039, (1994)